NEW YORK (TheStreet) -- Flamel Technologies (FLML) shares are down -4.75% to $10.82 in trading on Wednesday following the release of the company's first quarter earnings results.
The biotech company reported an adjust net loss of -$4.2 million, or -15 cents per diluted share, in line with analysts estimates.
Revenue for the quarter was up 78.5% to $9.2 million, beating analysts estimates of $7.47 million.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.